1. Home
  2. OFG vs NNNN Comparison

OFG vs NNNN Comparison

Compare OFG & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OFG Bancorp

OFG

OFG Bancorp

HOLD

Current Price

$41.46

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$32.20

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OFG
NNNN
Founded
1964
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
OFG
NNNN
Price
$41.46
$32.20
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$45.75
N/A
AVG Volume (30 Days)
258.0K
33.4K
Earning Date
01-22-2026
04-28-2026
Dividend Yield
2.90%
N/A
EPS Growth
6.55
N/A
EPS
4.40
0.06
Revenue
$624,004,000.00
$6,920,153.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.02
N/A
P/E Ratio
$9.39
$584.00
Revenue Growth
N/A
N/A
52 Week Low
$33.15
$5.18
52 Week High
$46.11
$55.65

Technical Indicators

Market Signals
Indicator
OFG
NNNN
Relative Strength Index (RSI) 51.97 53.52
Support Level $40.91 $27.32
Resistance Level $42.04 $35.45
Average True Range (ATR) 0.71 3.97
MACD -0.10 -0.10
Stochastic Oscillator 46.08 53.09

Price Performance

Historical Comparison
OFG
NNNN

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: